Santa Fe Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-42,832
Closed -$3.05M 86
2015
Q4
$3.05M Buy
+42,832
New +$2.88M 0.5% 47
2015
Q3
Sell
-29,024
Closed -$2.1M 495
2015
Q2
$2.1M Buy
+29,024
New +$2.14M 0.29% 127
2015
Q1
Sell
-26,797
Closed -$1.8M 523
2014
Q4
$1.8M Buy
26,797
+23,353
+678% +$1.47M 0.23% 191
2014
Q3
$209K Sell
3,444
-40,526
-92% -$2.5M 0.03% 480
2014
Q2
$2.58M Buy
+43,970
New +$2.57M 0.39% 78
2013
Q4
Sell
-6,185
Closed -$382K 494
2013
Q3
$382K Buy
+6,185
New +$370K 0.07% 349

Other funds holding DGX

Santa Fe Partners's DGX Position: Q1 2016 in Review

Santa Fe Partners sold out of Quest Diagnostics (DGX) in Q1 2016, closing a stake of 42,832 shares — an estimated $3.05M sold.

Santa Fe Partners first reported a position in DGX in Q3 2013 and held it in 6 quarters. The position peaked at $3.05M in Q4 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • Santa Fe Partners reported no remaining Quest Diagnostics position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 42,832 Quest Diagnostics shares in Q1 2016, an estimated $3.05M.
  • Santa Fe Partners first reported a position in Quest Diagnostics in Q3 2013 and held it in 6 quarters.
  • Santa Fe Partners's Quest Diagnostics position peaked at $3.05M in Q4 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.